• The BT-Reveal Early Pancreatic Cancer Test
  • Menopause
  • Glycogen storage disease type II (Pompe disease)
  • Congenital malformation
  • Nephrotic syndrome
  • Cardiovascular risk assessment
  • Pheochromocytoma
  • Abdominal aortic aneurysm
  • Glycogen storage disease type I (von Gierke disease)
  • Canavan's disease
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Serum
Medical Test

CPT
Access to Cancer Antigen (CA) 19-9, Serum is restricted.
Loading...